AGTR1 and cancer: AT1R is associated with adverse or cancer-related outcomes through the actions of VEGF, PDGF and FGF, in processes such as angiogenesis, proliferation, inflammation and fibrosis, while AT2R antagonizes these effects [10, 15, 16].